Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2442 participants.
Also called NCT07290699
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,442 participants
- Sponsor
- Registry
-
NCT07290699
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07290699. Randomized; no masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2027-08-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
- Acronym
- INCLINE-AMI
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Condition
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Intervention (Drug)
- Recaticimab
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Collaborator
- First Affiliated Hospital of Gannan Medical University
- Collaborator
- Jiujiang No.1 People's Hospital
- Collaborator
- First People's Hospital of FuZhou
- Collaborator
- Yueyang Central Hospital
- Collaborator
- The First People's Hospital of Changde City
- Collaborator
- ZhuZhou Central Hospital
- Collaborator
- Xiangtan Central Hospital
- Collaborator
- Loudi Central Hospital
Record details
- Record id
cardio:ct-nct07290699- Content hash
4eee6846084ce496b13f0612b7bc5923f31d9b201cd55afa7e9ff0b43fd3f6d5